CD INFORM: Investigating Natalizumab Through Further Observational Research and Monitoring

This study is currently recruiting participants.

Verified March 2012 by Elan Pharmaceuticals

Sponsor:

Collaborator:

Biogen Idec

Information provided by:

Elan Pharmaceuticals

ClinicalTrials.gov Identifier:

NCT00707512

First received: June 27, 2008

Last updated: March 15, 2012

Last verified: March 2012

No Study Results Posted on ClinicalTrials.gov for this Study

Study Status:	This study is currently recruiting participants.
Estimated Study Completion Date:	No date given
Estimated Primary Completion Date:	June 2017 (Final data collection date for primary outcome measure)